About Us

At Clinical Research Advantage, Inc. ("CRA"), we are committed to enhancing patient care by offering a mechanism for medical professionals to conduct phase II-IV clinical research trials. CRA has provided research services to the pharmaceutical industry for 18 years. With CRA, Pharmaceutical and Biotech companies have a unique source for conducting clinical drug trials. CRA is comprised of community based Investigators plus an experienced staff of Clinical Research Coordinators. The key to our success has been partnering in the development of research departments within established medical practices. Our research staff is positioned in the clinic, which affords CRA rapid recruitment of reliable, qualified subjects into clinical trials. CRA provides superior coordinating and regulatory support to these professionals in their efforts to introduce new and innovative medical treatments to their patients and the community. Our expertise continues throughout the trial, providing full execution of the protocol with complete and accurate data. Through excellence, accuracy, quality, innovation and compassion we are a premier comprehensive clinical research company providing phase II-IV research and drug development services to the biopharmaceutical industry.

CRA has successfully completed over 1,700 research studies in over 51 indications, our sites are consistently top-enrolling in numerous studies and consistently delivers high-quality, clean data. CRA, with its unparalleled clinical expertise, thorough regulatory department, state-of-the-art management processes and comprehensive recruitment practices consistently deliver clean, reliable data and rapid patient enrollment.

CRA’s trained and caring staff is always finding ways to make visitors feel welcome and appreciated. All clinical staff are NIH certified and, upon meeting credentialing requirements, coordinators are certified to ensure participant safety. The board-certified physicians overseeing the studies provide expert medical attention to study participants during a clinical trial.